139
Participants
Start Date
May 31, 2011
Primary Completion Date
January 31, 2014
Study Completion Date
January 31, 2014
AFQ056
Placebo
Novartis Investigative Site, Brussels
Novartis Investigative Site, Westmead
Novartis Investigative Site, Glostrup Municipality
Novartis Investigative Site, Leuven
Novartis Investigative Site, Parkville
Novartis Investigative Site, Zurich
Novartis Investigative Site, Staten Island
Novartis Investigative Site, Genova
Novartis Investigative Site, Spånga
Novartis Investigative Site, Málaga
Novartis Investigative Site, Decatur
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Padua
Novartis Investigative Site, Nashville
Novartis Investigative Site, Ramat Gan
Novartis Investigative Site, Mainz
Novartis Investigative Site, Chicago
Novartis Investigative Site, Bron
Novartis Investigative Site, Tübingen
Novartis Investigative Site, Paris
Novartis Investigative Site, Houston
Novartis Investigative Site, München
Novartis Investigative Site, München
Novartis Investigative Site, Sacramento
Novartis Investigative Site, Würzburg
Novartis Investigative Site, Boston
Novartis Investigative Site, Omaha
Novartis Investigative Site, Edmonton
Novartis Investigative Site, Vancouver
Novartis Investigative Site, Semarang
Novartis Investigative Site, Lausanne
Novartis Investigative Site, Montreal
Novartis Investigative Site, Dresden
Novartis Investigative Site, Roma
Novartis Investigative Site, Rotterdam
Novartis Investigative Site, Sabadell
Novartis Investigative Site, Sant Cugat del Vallès
Novartis Investigative Site, Edinburgh
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY